Sort publications on year
-
Pharmaco-Economics
Direct medical and non-medical costs of a one-year care pathway for early operable breast cancer: Results of a French multicenter prospective study
HEQUET D, HUCHON C, SOILLY AL, ASSELAIN B, BERSENEFF H, TRICHOT C, COMBES A, ALVES K, NGUYEN T, ROUZIER R, BAFFERT S.
PLoS One ; 2019;14(7)
-
Public Health and Epidemiology
Exposure of adults to extremely low frequency magnetic field in France: results of the EXPERS study.
MAGNE I, SOUQUES M, COUROUVE L, DUBURCQ A, REMY E, CABANES PA.
Radioprotection ; 2020;55(1),39-50
-
Biometry and database analysis
The Burden of Severe Asthma in France: A Case-Control Study Using a Medical Claims Database
BOURDIN A, FABRY-VENDRAND C, OSTINELLI J, AIT-YAHIA M, DARNAL E, BOUEE S, LAURENDEAU C, BUREAU I, GOURMELEN J, CHOUAID C.
J Allergy Clin Immunol Pract ; 2019;7(5):1477-1487
-
Pharmaco - Epidemiology
Predictors and burden of hospital readmission with recurrent Clostridioides difficile infection: a French nation-wide inception cohort study
DINH A, LE MONNIER A, EMERY C, ALAMI S, TORRETON É, DUBURCQ A, BARBIER F.
Eur J Clin Microbiol Infect Dis ; 2019
-
Biometry and database analysis
Migraine burden and costs in france: a nationwide claims database analysis of triptan users.
DONNET A, EMERY C, ALY S, ALLAF B, CAYRE F, MAHIEU N, GOURMELEN J, LEVY P, FAGNANI F.
J Med Econ ; 2019
-
Biometry and database analysis
Economic burden of chemotherapy-treated recurrent and/or metastatic squamous cell carcinoma of the head and neck in france: real world data from the permanent sample of national health insurance beneficiairies.
LAFUMA A, COTTÉ FE, LE TOURNEAU C, EMERY C, GAUDIN AF, TORRETON E, GOURMELEN J, BONASTRE J.
J Med Econ ; 2019
-
Biometry and database analysis
Factors associated with parathyroid hormone control in haemodialysis patients with secondary hyperparathyroidism treated with cinacalcet in real-world clinical practice : Mimosa study
ROTTEMBOURG J, URENA-TORRES P, TOLEDANO D, GUEUTIN V, HAMANI A, COLDEFY O, HEBIBI H, GUINCESTRE T, EMERY C.
Clinical Kidney Journal ; 2019;12(6):871-879
-
Public Health and Epidemiology
Remote Monitoring of Diabetes: A Cloud-Connected Digital System for Individuals With Diabetes and Their Health Care Providers.
JOUBERT M, BENHAMOU PY, SCHAEPELYNCK P, HANAIRE H, CATARGI B, FARRET A, FONTAINE P, GUERCI B, REZNIK Y, NATHALIE JEANDIDIER N, PENFORNIS A, BOROT S, CHAILLOUS L, FRANC S, SERUSCLAT P, KHERBACHI Y, BAVIERE E, DETOURNAY B, SIMON P, CHARPENTIER G.
J Diabetes Sci Technol ; 2019;13(6):1161-1168
-
Pharmaco-Economics
Long-term cost-effectiveness of the fixed-dose combination of tiotropium plus olodaterol based on the DYNAGITO trial results.
HOOGENDOORN M, CORRO RAMOS I, BALDWIN M, LUCIANI L, FABRON C, DETOURNAY B, PMH RUTTEN-VAN MÖLKEN M.
Int J Chron Obstruct Pulmon Dis ; 2019;14:447-456
-
Pharmaco-Economics
Cost-effectiveness of web-based patient-reported outcome surveillance in lung cancer patients.
LIZÉE T, BASCH E, TRÉMOLIÈRES P, VOOG E, DOMONT J, PEYRAGA G, URBAN T, BENNOUNA J, SEPTANS A-L, BALAVOINE M, DETOURNAY B, DENIS F.
J Thorac Oncol ; 2019;14(6):1012-1020
-
Public Health and Epidemiology
Early intervention for early psychosis in France, mapping of programs.
MEUNIER-CUSSAC S, GOZLAN G, LECARDEUR L, DUBURCQ A, COUROUVE L
Schizophrenia Bulletin ; 2018;44(S1):S125-S126
-
Others
Data sources, the data used, and the modality for collection
MERCIER G, COSTA N, DUTOT C, RICHE VP, BAFFERT S, French costing group
Rev Epidemiol Sante Publique ; 2018;66(S2):S73-S91
-
Pharmaco-Economics
[Standard or specific unit costs: Which criteria for choosing an economic evaluation of health strategies in multicentric studies?]
MARGIER J, BAFFERT S, LE CORROLLER-SORIANO AG, French Costing Group.
Rev Epidemiol Sante Publique ; 2018;66(S2):S93-S99
-
Public Health and Epidemiology
Prise en charge précoce des premiers épisodes psychotiques en France : cartographie des programmes spécialisés en 2017
GOZLAN G, MEUNIER-CUSSAC S, LECARDEUR L, DUBURCQ A, COUROUVE L
L’information psychiatrique ; 2018;94(5):393-401
-
Public Health and Epidemiology
Évaluation des coûts et des bénéfices pour la santé de la rénovation énergétique en France
EZRATTY V, ORMANDY D, LAURENT MH, BOUTIÈRE F, DUBURCQ A, COUROUVE L, CABANES PA.
Environ Risque Santé ; 2018;17(4):401-410
